Hamza Mahmood Bajwa

Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

Hamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson et al. · Multiple Sclerosis and Related Disorders · 2022 · 32 citations · Full text

Extended interval dosing with ocrelizumab in multiple sclerosis

Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard et al. · Multiple Sclerosis Journal · 2024 · 18 citations · Full text

Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses

Frederik Novak, Hamza Mahmood Bajwa, John Coia et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 15 citations · Full text